Evolva(瑞士)

Evolva SA

瑞士EvolvaSA www.evolva.com瑞士生物科技公司Evolva是一家研发治疗动脉血栓形成以及真菌感染的公司。而诺华投资（NovartisVenture）阿拉维（Aravis），太阳石资本（SunstoneCapita）以及丹麦创新资本集团（DanskInnovations）都是其投资者之一。Evolvawasfoundedin2004aroundadistinctive,propr ietary,technologyplatformthatusessyntheticbiologytocreateinnovativesmallmoleculedrugsandothercompounds.Inparticularourplatformallowsthecreationofchemistriesthatrecapitulatethethemesfoundinnaturalproducts,butwithoutthedisadvantagesofthoseapproaches.Wehaveusedthisplatformacrossarangeofpharmaceuticalandrelatedapplicationsandhavecreatedapipelineofstronglydifferentiatedcompoundsthataddressmajorunmetmedicalneeds.Ourcompoundsareorallyavailable,potentandcovernewstructuralclassesand/ornewmechanisms.Ourthreemostimportantcompoundsare:EV-077forrenaldiseaseandarterialthrombosis.EV-077isinPhaseIEV-086forfungalinfections.EV-086is